[1]
“ EVALUATION OF THE USE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW”, REMUNOM, vol. 12, no. 3, pp. 1–13, Nov. 2024, doi: 10.61164/rmnm.v12i3.3138.